UTHealth professor receives ACS grant to improve care and QOL for people with liver cancer

NewsGuard 100/100 Score

Curtis Wray, M.D., an assistant professor of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded a grant from the American Cancer Society to find ways to improve the care and quality of life for people with liver cancer. Liver cancer is the sixth most common type of cancer in the world and about 750,000 new cases were diagnosed in 2008.

Wray is using his 5-year, $729,000 grant to study disparities in the life expectancy of patients with advanced liver cancer, which averages about seven months but is considerably less in the underserved population. In an effort to pinpoint factors contributing to this disparity, Wray is following liver cancer patients in the Harris County Hospital District, which is the community's leading integrated healthcare system focused on caring for the medically underserved individuals and families in Harris County.

"We know the outcomes for people with liver cancer have been suboptimal in an underserved population," he said. "We want to know why and what can be done to improve the quality of life for these patients."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes